Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces immune-mediated
diseases. The pathophysiology of COVID-19 uses the following three mechanisms:(1) …

Alzheimer's disease and related dementias (ADRD) present significant challenges including
cognitive and functional loss, behavioral disruption, emotional distress, and significant …

While there is substantial evidence on excess mortality in the first two years of the COVID-19
pandemic, no study has conducted a cause-specific analysis of excess mortality for the …

Background: Recent research suggests that selective serotonin reuptake inhibitors (SSRIs)
may reduce mortality in COVID-19 patients; however, research into their benefits for elderly …

Aim Coronavirus disease 2019 (COVID-19) negatively impacts the progression of
Alzheimer's disease. The aim of this study was to determine whether mortality from …

Vaccination helps reduce the risk of coronavirus disease 2019 (COVID-19) infection in
elderly individuals with major neurocognitive disorders (MNDs). However, some caregivers …

Background Although several studies have documented the detrimental impacts of global
COVID-19 containment measures on individuals with Alzheimer's disease and dementia, a …

Objective This study investigates geographic variations in ADRD mortality in the US. By
considering both state of residence and state of birth, we aim to discern the relative …

Background US-focused studies have reported decreasing dementia prevalence in recent
decades, but have not yet focused on the implications of the COVID-19 pandemic for trends …

Objectives With the seeming end of the COVID-19 epidemic, international focus is rethinking
its spillover consequences, such as on the routine provision and usage of healthcare. This …